Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients

Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients

Dysregulation of immune response was observed in COVID-19 patients. Thymosin alpha 1 (Tα1) is used in the management of COVID-19, because it is known to restore the homeostasis of the immune system during infections and cancers. We aim to observe the longitudinal changes in T lymphocyte subsets and...

Full description

Bibliographic Details
Main Authors: Zhenyan Wang, Jun Chen, Cuiyun Zhu, Li Liu, Tangkai Qi, Yinzhong Shen, Yuyi Zhang, Lie Xu, Tao Li, Zhiping Qian, Corklin R. Steinhart, Hongzhou Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Immunology
Subjects:
COVID-19
thymosin alpha-1
T lymphocyte
CD4
CD8
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.568789/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.568789/full

Similar Items